Strikingly, we also observed a 2–5-fold increase of cytotoxic features of CD8pos T cells present in the TME in the majority of the melanoma after anti-Itgβ8 antibody treatment compared to untreated condition (Fig. 7e, f). The gene discussed is ITGB8; the disease is melanoma.